Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Riluzole

Na+ channel blocker, K+ channel activator
 
BML-NA138-0020 20 mg 61.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ALX-550-344

Glutamate release inhibitor. Neuroprotective. Blocks the inactivated state of voltage-gated neuronal Na+ channels at very low concentrations (about 0.1µM) and activates the TREK family of two-pore domain potassium channels.

Product Specification

Alternative Name:2-Amino-6-(trifluoromethoxy)-benzothiazole, 6-(Trifluoromethoxy)-2-benzothiazolamine
 
Formula:C8H5F3N2OS
 
MW:234.2
 
CAS:1744-22-5
 
MI:14: 8223
 
Purity:≥98% (TLC)
 
Appearance:White to off-white solid.
 
Solubility:Soluble in DMSO (>25mg/ml), 100% ethanol (>25mg/ml), methanol (>40mg/ml), 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin (14mg/ml) or in 0.1N HCl (11mg/ml); insoluble in water.
 
Shipping:Ambient
 
Long Term Storage:Ambient
 
Use/Stability:Stable for up to 1 year after receipt when stored at +20°C. Stock solutions are stable for up to 3 months at -20°C.
 
bml-na138
Please mouse over
bml-na138

Product Literature References

Do sodium channel blockers have neuroprotective effect after onset of ischemic insult?: O. Ates, et al.; Neurol. Res. 29, 317 (2007), Abstract;
Therapeutic potential of neuronal two-pore domain potassium-channel modulators: A. Mathie & E.L. Veale; Curr. Opin. Investig. Drugs 8, 555 (2007), Abstract;
Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels: J.H. Song, et al.; J. Pharmacol. Exp. Ther. 282, 707 (1997), Abstract;
Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats: M.C. Guyot, et al.; Neuroscience 81, 141 (1997), Abstract;
Inhibition by riluzole of glycinergic postsynaptic currents in rat hypoglossal motoneurons: M. Umemiya & A.J. Berger; Br. J. Pharmacol. 116, 3227 (1995), Abstract;
Na+ channels as targets for neuroprotective drugs: C.P. Taylor & B.S. Meldrum; TIPS 16, 309 (1995), (Review), Abstract;
Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures: A.G. Estevez, et al.; Eur. J. Pharmacol. 280, 47 (1995), Abstract;
Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study: A. Benazzouz, et al.; Eur. J. Pharmacol. 284, 299 (1995), Abstract;
Anesthetic properties of riluzole (54274 RP), a new inhibitor of glutamate neurotransmission: J. Mantz, et al.; Anesthesiology 76, 844 (1992), Abstract;
Effects of riluzole (2-amino-6-trifluoromethoxy benzothiazole) on striatal neurochemical markers in the rat, with special reference to the dopamine, choline, GABA and glutamate synaptosomal high affin: D. Samuel, et al.; Fundam. Clin. Pharmacol. 6, 177 (1992), Abstract;
Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia: J. Pratt, et al.; Neurosci. Lett. 140, 225 (1992), Abstract;

Related Literature

Brochures
Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,